Literature DB >> 9506780

In vivo model to study the biocompatibility of peritoneal dialysis solutions.

K Wieczorowska-Tobis1, K Korybalska, A Polubinska, M Radkowski, A Breborowicz, D G Oreopoulos.   

Abstract

This study was designed to analyze the complex morphologic and functional effects of dialysis solutions on peritoneum in a rat model on chronic peritoneal dialysis. Peritoneal catheters were inserted into 10 male, Wistar rats and the animals were dialyzed twice daily for 4 weeks with 4.25% Dianeal. During the study we observed two opposite effects: healing of the peritoneum after catheter implantation--decreased cell count in dialysate, decreased permeability of the peritoneum to glucose and total protein, increased volume of drained dialysate; and damage to the membrane due to its exposure to peritoneal dialysis solution--increased hyaluronic acid levels in dialysate, a tendency of the peritoneum to thicken when compared to non-dialyzed animals. Our rat model of CAPD may be used for quantitative and qualitative assessment of the effects of peritoneal dialysis solution on the peritoneum during chronic dialysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9506780

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  3 in total

1.  Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?

Authors:  Karima Farhat; Frans Jan van Ittersum; Piet Marten Ter Wee; Caroline Ellen Douma
Journal:  NDT Plus       Date:  2008-10

2.  Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis.

Authors:  Lan Zhou; Ming Zong; Qiunong Guan; Gerald da Roza; Hao Wang; Hualin Qi; Caigan Du
Journal:  Stem Cells Int       Date:  2019-09-16       Impact factor: 5.443

Review 3.  Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience.

Authors:  Krzysztof Pawlaczyk; Ewa Baum; Krzysztof Schwermer; Krzysztof Hoppe; Bengt Lindholm; Andrzej Breborowicz
Journal:  Biomed Res Int       Date:  2015-07-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.